Switching HIV-infected, suppressed patients from ABC/3TC to FTC/TDF improves lipids - the SETTLE study

被引：0
|
作者：
Gathe, J. C., Jr. [1 ]
机构：
[1] Therapeut Concepts, Houston, TX USA
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A61 / A62
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
    R. Palacios
    I. A. Pérez-Hernández
    M. A. Martínez
    M. L. Mayorga
    C. M. González-Domenech
    M. Omar
    J. Olalla
    A. Romero
    J. M. Romero
    I. Pérez-Camacho
    J. Hernández-Quero
    J. Santos
    European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35 : 815 - 819
  • [2] Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
    Palacios, R.
    Perez-Hernandez, I. A.
    Martinez, M. A.
    Mayorga, M. L.
    Gonzalez-Domenech, C. M.
    Omar, M.
    Olalla, J.
    Romero, A.
    Romero, J. M.
    Perez-Camacho, I.
    Hernandez-Quero, J.
    Santos, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (05) : 815 - 819
  • [3] RENAL TOXICITY FOR SWITCHING FROM TENOFOVIR/EMTRICITABINE (TDF/FTC) TO ABACAVIR/LAMIVUDINE (ABC/3TC): AN ASSOCIATION TO BE CLARIFIED
    Manzini, L.
    Borghi, V.
    Rusconi, S.
    Vergani, B.
    Bonfanti, P.
    Calza, L.
    Narciso, P.
    Lenoci, F.
    Maggi, P.
    Mussini, C.
    INFECTION, 2011, 39 : S66 - S67
  • [4] Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study
    Cicalini, Stefania
    Lanini, Simone
    Gagliardini, Roberta
    Bellagamba, Rita
    Vergori, Alessandra
    Mastrorosa, Ilaria
    Mazzotta, Valentina
    Esvan, Rozenn
    Plazzi, Maria Maddalena
    Ottou, Sandrine
    Grilli, Elisabetta
    De Zottis, Federico
    Fusto, Marisa
    Paulicelli, Jessica
    Antinori, Andrea
    PHARMACEUTICALS, 2024, 17 (12)
  • [5] Switching Tenofovir/Emtricitabine/Efavirenz (TDF/FTC/EFV) to TDF/FTC/Rilpivirine vs Continuing TDF/FTC/EFV in HIV-Infected Patients With Virological Suppression: A Randomized Controlled Trial
    Wiriyatanakorn, Sirichai
    Sungkanuparph, Somnuek
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (07):
  • [6] Efficacy and safety of switching to co-formulated DOR/TDF/3TC in virologically suppressed HIV-1-infected patients: early experience from a single Italian centre
    Lagi, F.
    Formica, G.
    Ducci, F.
    Kiros, S. Tekle
    Pozzi, M.
    Bartalesi, F.
    Corsi, P.
    Malcontenti, C.
    Sterrantino, G.
    Bartoloni, A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 105 - 106
  • [7] Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (TruvadaA®) in virologically suppressed HIV-infected patients on HAART
    Palacios, R.
    Hidalgo, C.
    Rios, M. J.
    Rivero, A.
    Munoz, L.
    Lozano, F.
    Gutierrez-Rave, V.
    Galvez, M. C.
    del Arco, A.
    Santos, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (04) : 399 - 402
  • [8] Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada®) in virologically suppressed HIV-infected patients on HAART
    R. Palacios
    C. Hidalgo
    M. J. Ríos
    A. Rivero
    L. Muñoz
    F. Lozano
    V. Gutiérrez-Ravé
    M. C. Gálvez
    A. del Arco
    J. Santos
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28 : 399 - 402
  • [9] SWIFT study: switching from lamivudine/abacavir (3TC/ABC) to emtricitabine/tenofovir DF (FTC/TDF) improved fasting lipid parameters while maintaining virologic suppression
    DeJesus, E.
    Campo, R.
    Bredeek, F.
    Wang, H.
    Dau, L.
    Fralich, T.
    ANTIVIRAL THERAPY, 2011, 16 : A55 - A56
  • [10] Increase in bone mineral density and weight in women who switch from TDF/FTC/NNRTI to ABC/3TC/DTG
    Samarawickrama, A.
    Hamzah, L.
    Ibrahim, F.
    Ainsworth, J.
    Fox, J.
    Gilleece, Y.
    Hemat, N.
    Johnson, M.
    Kegg, S.
    Orkin, C.
    Prime, K.
    Waters, L.
    Barbini, B.
    Campbell, L.
    Post, F.
    HIV MEDICINE, 2020, 21 : 13 - 13
12345